ヘパリンナトリウム原薬のグローバル市場 2021年：企業別、地域別、種類・用途別

• 英文タイトル：Global Heparin Sodium Active Pharmaceutical Ingredient Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-203B16411 • 出版社/出版日：GlobalInfoResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

ヘパリンナトリウム原薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のヘパリンナトリウム原薬の市場規模は2020年のxxx米ドルから2021年にはxxx米ドルと推定され、2020年から2021年の間にxxx％の変化があります。世界のヘパリンナトリウム原薬の市場規模は次の5年間でxxx％のCAGRで成長すると予想されます。 ヘパリンナトリウム原薬市場は種類と用途によって区分されます。2016年～2026年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・ヘパリンナトリウム、ヘパリンカルシウム 用途別セグメントは次のように区分されます。 ・低分子ヘパリン製剤、標準ヘパリン製剤 世界のヘパリンナトリウム原薬市場の主要な市場プレーヤーは以下のとおりです。 ・Hepalink、King-friend Biochemical Pharmaceutical、Bioibérica、Dongcheng Biochemicals、Changshan Pharm、Pfizer、Jiulong Biochemicals、Qianhong Bio-pharma、Tiandong、Opocrin、Yino Pharma Limited、Xinbai、Deebio 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計14章あります。 ・第1章では、ヘパリンナトリウム原薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なヘパリンナトリウム原薬メーカーの企業概要、2019年～2021年までのヘパリンナトリウム原薬の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なヘパリンナトリウム原薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2016年～2026年までの地域別ヘパリンナトリウム原薬の販売量、売上、成長性を示しています。 ・第5、6章では、2016年～2026年までのヘパリンナトリウム原薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2016年～2021年までの世界の主要国での販売量、売上、市場シェア、並びに2021年～2026年までの主要地域でのヘパリンナトリウム原薬市場予測を収録しています。 ・第12、13、14章では、ヘパリンナトリウム原薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Hepalink、King-friend Biochemical Pharmaceutical、Bioibérica、Dongcheng Biochemicals、Changshan Pharm、Pfizer、Jiulong Biochemicals、Qianhong Bio-pharma、Tiandong、Opocrin、Yino Pharma Limited、Xinbai、Deebio ・メーカー別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ヘパリンナトリウム、ヘパリンカルシウム ・用途別分析2016年-2026年：低分子ヘパリン製剤、標準ヘパリン製剤 ・ヘパリンナトリウム原薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ヘパリンナトリウム原薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ヘパリンナトリウム原薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ヘパリンナトリウム原薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ヘパリンナトリウム原薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Heparin Sodium Active Pharmaceutical Ingredient market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Heparin Sodium Active Pharmaceutical Ingredient size is estimated to be million in 2021 from USD million in 2020, with a change of % between 2020 and 2021. The global Heparin Sodium Active Pharmaceutical Ingredient market size is expected to grow at a CAGR of % for the next five years.

Market segmentation
Heparin Sodium Active Pharmaceutical Ingredient market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Heparin Sodium
Heparin Calcium

Market segment by Application can be divided into
Low Molecular Heparin Preparation
Standard Heparin Preparation

The key market players for global Heparin Sodium Active Pharmaceutical Ingredient market are listed below:
Hepalink
King-friend Biochemical Pharmaceutical
Bioibérica
Dongcheng Biochemicals
Changshan Pharm
Pfizer
Jiulong Biochemicals
Qianhong Bio-pharma
Tiandong
Opocrin
Yino Pharma Limited
Xinbai
Deebio

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Heparin Sodium Active Pharmaceutical Ingredient product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Heparin Sodium Active Pharmaceutical Ingredient, with price, sales, revenue and global market share of Heparin Sodium Active Pharmaceutical Ingredient from 2019 to 2021.
Chapter 3, the Heparin Sodium Active Pharmaceutical Ingredient competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Heparin Sodium Active Pharmaceutical Ingredient breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Heparin Sodium Active Pharmaceutical Ingredient market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Heparin Sodium Active Pharmaceutical Ingredient sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Heparin Sodium Active Pharmaceutical Ingredient Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Heparin Sodium Active Pharmaceutical Ingredient Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Heparin Sodium
1.2.3 Heparin Calcium
1.3 Market Analysis by Application
1.3.1 Overview: Global Heparin Sodium Active Pharmaceutical Ingredient Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Low Molecular Heparin Preparation
1.3.3 Standard Heparin Preparation
1.4 Global Heparin Sodium Active Pharmaceutical Ingredient Market Size & Forecast
1.4.1 Global Heparin Sodium Active Pharmaceutical Ingredient Sales in Value (2016-2026))
1.4.2 Global Heparin Sodium Active Pharmaceutical Ingredient Sales in Volume (2016-2026)
1.4.3 Global Heparin Sodium Active Pharmaceutical Ingredient Price by Type (2016-2026) & (US$/Billion Untis)
1.5 Global Heparin Sodium Active Pharmaceutical Ingredient Production Capacity Analysis
1.5.1 Global Heparin Sodium Active Pharmaceutical Ingredient Total Production Capacity (2016-2026)
1.5.2 Global Heparin Sodium Active Pharmaceutical Ingredient Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Heparin Sodium Active Pharmaceutical Ingredient Market Drivers
1.6.2 Heparin Sodium Active Pharmaceutical Ingredient Market Restraints
1.6.3 Heparin Sodium Active Pharmaceutical Ingredient Trends Analysis
2 Manufacturers Profiles
2.1 Hepalink
2.1.1 Hepalink Details
2.1.2 Hepalink Major Business
2.1.3 Hepalink Heparin Sodium Active Pharmaceutical Ingredient Product and Services
2.1.4 Hepalink Heparin Sodium Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 King-friend Biochemical Pharmaceutical
2.2.1 King-friend Biochemical Pharmaceutical Details
2.2.2 King-friend Biochemical Pharmaceutical Major Business
2.2.3 King-friend Biochemical Pharmaceutical Heparin Sodium Active Pharmaceutical Ingredient Product and Services
2.2.4 King-friend Biochemical Pharmaceutical Heparin Sodium Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Bioibérica
2.3.1 Bioibérica Details
2.3.2 Bioibérica Major Business
2.3.3 Bioibérica Heparin Sodium Active Pharmaceutical Ingredient Product and Services
2.3.4 Bioibérica Heparin Sodium Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Dongcheng Biochemicals
2.4.1 Dongcheng Biochemicals Details
2.4.2 Dongcheng Biochemicals Major Business
2.4.3 Dongcheng Biochemicals Heparin Sodium Active Pharmaceutical Ingredient Product and Services
2.4.4 Dongcheng Biochemicals Heparin Sodium Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Changshan Pharm
2.5.1 Changshan Pharm Details
2.5.2 Changshan Pharm Major Business
2.5.3 Changshan Pharm Heparin Sodium Active Pharmaceutical Ingredient Product and Services
2.5.4 Changshan Pharm Heparin Sodium Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business
2.6.3 Pfizer Heparin Sodium Active Pharmaceutical Ingredient Product and Services
2.6.4 Pfizer Heparin Sodium Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Jiulong Biochemicals
2.7.1 Jiulong Biochemicals Details
2.7.2 Jiulong Biochemicals Major Business
2.7.3 Jiulong Biochemicals Heparin Sodium Active Pharmaceutical Ingredient Product and Services
2.7.4 Jiulong Biochemicals Heparin Sodium Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Qianhong Bio-pharma
2.8.1 Qianhong Bio-pharma Details
2.8.2 Qianhong Bio-pharma Major Business
2.8.3 Qianhong Bio-pharma Heparin Sodium Active Pharmaceutical Ingredient Product and Services
2.8.4 Qianhong Bio-pharma Heparin Sodium Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Tiandong
2.9.1 Tiandong Details
2.9.2 Tiandong Major Business
2.9.3 Tiandong Heparin Sodium Active Pharmaceutical Ingredient Product and Services
2.9.4 Tiandong Heparin Sodium Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Opocrin
2.10.1 Opocrin Details
2.10.2 Opocrin Major Business
2.10.3 Opocrin Heparin Sodium Active Pharmaceutical Ingredient Product and Services
2.10.4 Opocrin Heparin Sodium Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Yino Pharma Limited
2.11.1 Yino Pharma Limited Details
2.11.2 Yino Pharma Limited Major Business
2.11.3 Yino Pharma Limited Heparin Sodium Active Pharmaceutical Ingredient Product and Services
2.11.4 Yino Pharma Limited Heparin Sodium Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Xinbai
2.12.1 Xinbai Details
2.12.2 Xinbai Major Business
2.12.3 Xinbai Heparin Sodium Active Pharmaceutical Ingredient Product and Services
2.12.4 Xinbai Heparin Sodium Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Deebio
2.13.1 Deebio Details
2.13.2 Deebio Major Business
2.13.3 Deebio Heparin Sodium Active Pharmaceutical Ingredient Product and Services
2.13.4 Deebio Heparin Sodium Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Heparin Sodium Active Pharmaceutical Ingredient Sales by Manufacturer
3.1 Global Heparin Sodium Active Pharmaceutical Ingredient Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Heparin Sodium Active Pharmaceutical Ingredient Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Heparin Sodium Active Pharmaceutical Ingredient
3.4 Market Concentration Rate
3.4.1 Top 3 Heparin Sodium Active Pharmaceutical Ingredient Manufacturer Market Share
3.4.2 Top 6 Heparin Sodium Active Pharmaceutical Ingredient Manufacturer Market Share
3.5 Global Heparin Sodium Active Pharmaceutical Ingredient Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Heparin Sodium Active Pharmaceutical Ingredient Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Heparin Sodium Active Pharmaceutical Ingredient Market Size by Region
4.1.1 Global Heparin Sodium Active Pharmaceutical Ingredient Sales in Volume by Region (2016-2026)
4.1.2 Global Heparin Sodium Active Pharmaceutical Ingredient Revenue by Region (2016-2026)
4.2 North America Heparin Sodium Active Pharmaceutical Ingredient Revenue (2016-2026)
4.3 Europe Heparin Sodium Active Pharmaceutical Ingredient Revenue (2016-2026)
4.4 Asia-Pacific Heparin Sodium Active Pharmaceutical Ingredient Revenue (2016-2026)
4.5 South America Heparin Sodium Active Pharmaceutical Ingredient Revenue (2016-2026)
4.6 Middle East and Africa Heparin Sodium Active Pharmaceutical Ingredient Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Heparin Sodium Active Pharmaceutical Ingredient Sales in Volume by Type (2016-2026)
5.2 Global Heparin Sodium Active Pharmaceutical Ingredient Revenue by Type (2016-2026)
5.3 Global Heparin Sodium Active Pharmaceutical Ingredient Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Heparin Sodium Active Pharmaceutical Ingredient Sales in Volume by Application (2016-2026)
6.2 Global Heparin Sodium Active Pharmaceutical Ingredient Revenue by Application (2016-2026)
6.3 Global Heparin Sodium Active Pharmaceutical Ingredient Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Heparin Sodium Active Pharmaceutical Ingredient Sales by Type (2016-2026)
7.2 North America Heparin Sodium Active Pharmaceutical Ingredient Sales by Application (2016-2026)
7.3 North America Heparin Sodium Active Pharmaceutical Ingredient Market Size by Country
7.3.1 North America Heparin Sodium Active Pharmaceutical Ingredient Sales in Volume by Country (2016-2026)
7.3.2 North America Heparin Sodium Active Pharmaceutical Ingredient Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Heparin Sodium Active Pharmaceutical Ingredient Sales by Type (2016-2026)
8.2 Europe Heparin Sodium Active Pharmaceutical Ingredient Sales by Application (2016-2026)
8.3 Europe Heparin Sodium Active Pharmaceutical Ingredient Market Size by Country
8.3.1 Europe Heparin Sodium Active Pharmaceutical Ingredient Sales in Volume by Country (2016-2026)
8.3.2 Europe Heparin Sodium Active Pharmaceutical Ingredient Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Heparin Sodium Active Pharmaceutical Ingredient Sales by Type (2016-2026)
9.2 Asia-Pacific Heparin Sodium Active Pharmaceutical Ingredient Sales by Application (2016-2026)
9.3 Asia-Pacific Heparin Sodium Active Pharmaceutical Ingredient Market Size by Region
9.3.1 Asia-Pacific Heparin Sodium Active Pharmaceutical Ingredient Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Heparin Sodium Active Pharmaceutical Ingredient Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Heparin Sodium Active Pharmaceutical Ingredient Sales by Type (2016-2026)
10.2 South America Heparin Sodium Active Pharmaceutical Ingredient Sales by Application (2016-2026)
10.3 South America Heparin Sodium Active Pharmaceutical Ingredient Market Size by Country
10.3.1 South America Heparin Sodium Active Pharmaceutical Ingredient Sales in Volume by Country (2016-2026)
10.3.2 South America Heparin Sodium Active Pharmaceutical Ingredient Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Heparin Sodium Active Pharmaceutical Ingredient Sales by Type (2016-2026)
11.2 Middle East & Africa Heparin Sodium Active Pharmaceutical Ingredient Sales by Application (2016-2026)
11.3 Middle East & Africa Heparin Sodium Active Pharmaceutical Ingredient Market Size by Country
11.3.1 Middle East & Africa Heparin Sodium Active Pharmaceutical Ingredient Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Heparin Sodium Active Pharmaceutical Ingredient Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Heparin Sodium Active Pharmaceutical Ingredient Typical Distributors
12.3 Heparin Sodium Active Pharmaceutical Ingredient Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Heparin Sodium Active Pharmaceutical Ingredient Revenue by Type, (USD Million), 2021-2026
Table 2. Global Heparin Sodium Active Pharmaceutical Ingredient Revenue by Application, (USD Million), 2021-2026
Table 3. Hepalink Basic Information, Manufacturing Base and Competitors
Table 4. Hepalink Major Business
Table 5. Hepalink Heparin Sodium Active Pharmaceutical Ingredient Product and Services
Table 6. Hepalink Heparin Sodium Active Pharmaceutical Ingredient Sales (Billion Units), Price (US$/Billion Untis), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. King-friend Biochemical Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 8. King-friend Biochemical Pharmaceutical Major Business
Table 9. King-friend Biochemical Pharmaceutical Heparin Sodium Active Pharmaceutical Ingredient Product and Services
Table 10. King-friend Biochemical Pharmaceutical Heparin Sodium Active Pharmaceutical Ingredient Sales (Billion Units), Price (US$/Billion Untis), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Bioibérica Basic Information, Manufacturing Base and Competitors
Table 12. Bioibérica Major Business
Table 13. Bioibérica Heparin Sodium Active Pharmaceutical Ingredient Product and Services
Table 14. Bioibérica Heparin Sodium Active Pharmaceutical Ingredient Sales (Billion Units), Price (US$/Billion Untis), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Dongcheng Biochemicals Basic Information, Manufacturing Base and Competitors
Table 16. Dongcheng Biochemicals Major Business
Table 17. Dongcheng Biochemicals Heparin Sodium Active Pharmaceutical Ingredient Product and Services
Table 18. Dongcheng Biochemicals Heparin Sodium Active Pharmaceutical Ingredient Sales (Billion Units), Price (US$/Billion Untis), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Changshan Pharm Basic Information, Manufacturing Base and Competitors
Table 20. Changshan Pharm Major Business
Table 21. Changshan Pharm Heparin Sodium Active Pharmaceutical Ingredient Product and Services
Table 22. Changshan Pharm Heparin Sodium Active Pharmaceutical Ingredient Sales (Billion Units), Price (US$/Billion Untis), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Pfizer Basic Information, Manufacturing Base and Competitors
Table 24. Pfizer Major Business
Table 25. Pfizer Heparin Sodium Active Pharmaceutical Ingredient Product and Services
Table 26. Pfizer Heparin Sodium Active Pharmaceutical Ingredient Sales (Billion Units), Price (US$/Billion Untis), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Jiulong Biochemicals Basic Information, Manufacturing Base and Competitors
Table 28. Jiulong Biochemicals Major Business
Table 29. Jiulong Biochemicals Heparin Sodium Active Pharmaceutical Ingredient Product and Services
Table 30. Jiulong Biochemicals Heparin Sodium Active Pharmaceutical Ingredient Sales (Billion Units), Price (US$/Billion Untis), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Qianhong Bio-pharma Basic Information, Manufacturing Base and Competitors
Table 32. Qianhong Bio-pharma Major Business
Table 33. Qianhong Bio-pharma Heparin Sodium Active Pharmaceutical Ingredient Product and Services
Table 34. Qianhong Bio-pharma Heparin Sodium Active Pharmaceutical Ingredient Sales (Billion Units), Price (US$/Billion Untis), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Tiandong Basic Information, Manufacturing Base and Competitors
Table 36. Tiandong Major Business
Table 37. Tiandong Heparin Sodium Active Pharmaceutical Ingredient Product and Services
Table 38. Tiandong Heparin Sodium Active Pharmaceutical Ingredient Sales (Billion Units), Price (US$/Billion Untis), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Opocrin Basic Information, Manufacturing Base and Competitors
Table 40. Opocrin Major Business
Table 41. Opocrin Heparin Sodium Active Pharmaceutical Ingredient Product and Services
Table 42. Opocrin Heparin Sodium Active Pharmaceutical Ingredient Sales (Billion Units), Price (US$/Billion Untis), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Yino Pharma Limited Basic Information, Manufacturing Base and Competitors
Table 44. Yino Pharma Limited Major Business
Table 45. Yino Pharma Limited Heparin Sodium Active Pharmaceutical Ingredient Product and Services
Table 46. Yino Pharma Limited Heparin Sodium Active Pharmaceutical Ingredient Sales (Billion Units), Price (US$/Billion Untis), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Xinbai Basic Information, Manufacturing Base and Competitors
Table 48. Xinbai Major Business
Table 49. Xinbai Heparin Sodium Active Pharmaceutical Ingredient Product and Services
Table 50. Xinbai Heparin Sodium Active Pharmaceutical Ingredient Sales (Billion Units), Price (US$/Billion Untis), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Deebio Basic Information, Manufacturing Base and Competitors
Table 52. Deebio Major Business
Table 53. Deebio Heparin Sodium Active Pharmaceutical Ingredient Product and Services
Table 54. Deebio Heparin Sodium Active Pharmaceutical Ingredient Sales (Billion Units), Price (US$/Billion Untis), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Global Heparin Sodium Active Pharmaceutical Ingredient Sales by Manufacturer (2019-2021e) & (Billion Units)
Table 56. Global Heparin Sodium Active Pharmaceutical Ingredient Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 57. Market Position of Manufacturers in Heparin Sodium Active Pharmaceutical Ingredient, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 58. Global Heparin Sodium Active Pharmaceutical Ingredient Production Capacity by Company, (Billion Units): 2020 VS 2021
Table 59. Head Office and Heparin Sodium Active Pharmaceutical Ingredient Production Site of Key Manufacturer
Table 60. Heparin Sodium Active Pharmaceutical Ingredient New Entrant and Capacity Expansion Plans
Table 61. Heparin Sodium Active Pharmaceutical Ingredient Mergers & Acquisitions in the Past Five Years
Table 62. Global Heparin Sodium Active Pharmaceutical Ingredient Sales by Region (2016-2021e) & (Billion Units)
Table 63. Global Heparin Sodium Active Pharmaceutical Ingredient Sales by Region (2021-2026) & (Billion Units)
Table 64. Global Heparin Sodium Active Pharmaceutical Ingredient Revenue by Region (2016-2021e) & (USD Million)
Table 65. Global Heparin Sodium Active Pharmaceutical Ingredient Revenue by Region (2021-2026) & (USD Million)
Table 66. Global Heparin Sodium Active Pharmaceutical Ingredient Sales by Type (2016-2021e) & (Billion Units)
Table 67. Global Heparin Sodium Active Pharmaceutical Ingredient Sales by Type (2021-2026) & (Billion Units)
Table 68. Global Heparin Sodium Active Pharmaceutical Ingredient Revenue by Type (2016-2021e) & (USD Million)
Table 69. Global Heparin Sodium Active Pharmaceutical Ingredient Revenue by Type (2021-2026) & (USD Million)
Table 70. Global Heparin Sodium Active Pharmaceutical Ingredient Price by Type (2016-2021e) & (US$/Billion Untis)
Table 71. Global Heparin Sodium Active Pharmaceutical Ingredient Price by Type (2021-2026) & (US$/Billion Untis)
Table 72. Global Heparin Sodium Active Pharmaceutical Ingredient Sales by Application (2016-2021e) & (Billion Units)
Table 73. Global Heparin Sodium Active Pharmaceutical Ingredient Sales by Application (2021-2026) & (Billion Units)
Table 74. Global Heparin Sodium Active Pharmaceutical Ingredient Revenue by Application (2016-2021e) & (USD Million)
Table 75. Global Heparin Sodium Active Pharmaceutical Ingredient Revenue by Application (2021-2026) & (USD Million)
Table 76. Global Heparin Sodium Active Pharmaceutical Ingredient Price by Application (2016-2021e) & (US$/Billion Untis)
Table 77. Global Heparin Sodium Active Pharmaceutical Ingredient Price by Application (2021-2026) & (US$/Billion Untis)
Table 78. North America Heparin Sodium Active Pharmaceutical Ingredient Sales by Country (2016-2021e) & (Billion Units)
Table 79. North America Heparin Sodium Active Pharmaceutical Ingredient Sales by Country (2021-2026) & (Billion Units)
Table 80. North America Heparin Sodium Active Pharmaceutical Ingredient Revenue by Country (2016-2021e) & (USD Million)
Table 81. North America Heparin Sodium Active Pharmaceutical Ingredient Revenue by Country (2021-2026) & (USD Million)
Table 82. North America Heparin Sodium Active Pharmaceutical Ingredient Sales by Type (2016-2021e) & (Billion Units)
Table 83. North America Heparin Sodium Active Pharmaceutical Ingredient Sales by Type (2021-2026) & (Billion Units)
Table 84. North America Heparin Sodium Active Pharmaceutical Ingredient Sales by Application (2016-2021e) & (Billion Units)
Table 85. North America Heparin Sodium Active Pharmaceutical Ingredient Sales by Application (2021-2026) & (Billion Units)
Table 86. Europe Heparin Sodium Active Pharmaceutical Ingredient Sales by Country (2016-2021e) & (Billion Units)
Table 87. Europe Heparin Sodium Active Pharmaceutical Ingredient Sales by Country (2021-2026) & (Billion Units)
Table 88. Europe Heparin Sodium Active Pharmaceutical Ingredient Revenue by Country (2016-2021e) & (USD Million)
Table 89. Europe Heparin Sodium Active Pharmaceutical Ingredient Revenue by Country (2021-2026) & (USD Million)
Table 90. Europe Heparin Sodium Active Pharmaceutical Ingredient Sales by Type (2016-2021e) & (Billion Units)
Table 91. Europe Heparin Sodium Active Pharmaceutical Ingredient Sales by Type (2021-2026) & (Billion Units)
Table 92. Europe Heparin Sodium Active Pharmaceutical Ingredient Sales by Application (2016-2021e) & (Billion Units)
Table 93. Europe Heparin Sodium Active Pharmaceutical Ingredient Sales by Application (2021-2026) & (Billion Units)
Table 94. Asia-Pacific Heparin Sodium Active Pharmaceutical Ingredient Sales by Region (2016-2021e) & (Billion Units)
Table 95. Asia-Pacific Heparin Sodium Active Pharmaceutical Ingredient Sales by Region (2021-2026) & (Billion Units)
Table 96. Asia-Pacific Heparin Sodium Active Pharmaceutical Ingredient Revenue by Region (2016-2021e) & (USD Million)
Table 97. Asia-Pacific Heparin Sodium Active Pharmaceutical Ingredient Revenue by Region (2021-2026) & (USD Million)
Table 98. Asia-Pacific Heparin Sodium Active Pharmaceutical Ingredient Sales by Type (2016-2021e) & (Billion Units)
Table 99. Asia-Pacific Heparin Sodium Active Pharmaceutical Ingredient Sales by Type (2021-2026) & (Billion Units)
Table 100. Asia-Pacific Heparin Sodium Active Pharmaceutical Ingredient Sales by Application (2016-2021e) & (Billion Units)
Table 101. Asia-Pacific Heparin Sodium Active Pharmaceutical Ingredient Sales by Application (2021-2026) & (Billion Units)
Table 102. South America Heparin Sodium Active Pharmaceutical Ingredient Sales by Country (2016-2021e) & (Billion Units)
Table 103. South America Heparin Sodium Active Pharmaceutical Ingredient Sales by Country (2021-2026) & (Billion Units)
Table 104. South America Heparin Sodium Active Pharmaceutical Ingredient Revenue by Country (2016-2021e) & (USD Million)
Table 105. South America Heparin Sodium Active Pharmaceutical Ingredient Revenue by Country (2021-2026) & (USD Million)
Table 106. South America Heparin Sodium Active Pharmaceutical Ingredient Sales by Type (2016-2021e) & (Billion Units)
Table 107. South America Heparin Sodium Active Pharmaceutical Ingredient Sales by Type (2021-2026) & (Billion Units)
Table 108. South America Heparin Sodium Active Pharmaceutical Ingredient Sales by Application (2016-2021e) & (Billion Units)
Table 109. South America Heparin Sodium Active Pharmaceutical Ingredient Sales by Application (2021-2026) & (Billion Units)
Table 110. Middle East & Africa Heparin Sodium Active Pharmaceutical Ingredient Sales by Country (2016-2021e) & (Billion Units)
Table 111. Middle East & Africa Heparin Sodium Active Pharmaceutical Ingredient Sales by Country (2021-2026) & (Billion Units)
Table 112. Middle East & Africa Heparin Sodium Active Pharmaceutical Ingredient Revenue by Country (2016-2021e) & (USD Million)
Table 113. Middle East & Africa Heparin Sodium Active Pharmaceutical Ingredient Revenue by Country (2021-2026) & (USD Million)
Table 114. Middle East & Africa Heparin Sodium Active Pharmaceutical Ingredient Sales by Type (2016-2021e) & (Billion Units)
Table 115. Middle East & Africa Heparin Sodium Active Pharmaceutical Ingredient Sales by Type (2021-2026) & (Billion Units)
Table 116. Middle East & Africa Heparin Sodium Active Pharmaceutical Ingredient Sales by Application (2016-2021e) & (Billion Units)
Table 117. Middle East & Africa Heparin Sodium Active Pharmaceutical Ingredient Sales by Application (2021-2026) & (Billion Units)
Table 118. Direct Channel Pros & Cons
Table 119. Indirect Channel Pros & Cons
Table 120. Heparin Sodium Active Pharmaceutical Ingredient Typical Distributors
Table 121. Heparin Sodium Active Pharmaceutical Ingredient Typical Customers
List of Figures
Figure 1. Heparin Sodium Active Pharmaceutical Ingredient Picture
Figure 2. Global Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Type in 2020
Figure 3. Heparin Sodium
Figure 4. Heparin Calcium
Figure 5. Global Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Application in 2020
Figure 6. Low Molecular Heparin Preparation
Figure 7. Standard Heparin Preparation
Figure 8. Global Heparin Sodium Active Pharmaceutical Ingredient Market Size, (USD Million) & (Billion Units): 2020 VS 2021 VS 2026
Figure 9. Global Heparin Sodium Active Pharmaceutical Ingredient Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. Global Heparin Sodium Active Pharmaceutical Ingredient Sales (2016-2026) & (Billion Units)
Figure 11. Global Heparin Sodium Active Pharmaceutical Ingredient Price by Type (2016-2026) & (US$/Billion Untis)
Figure 12. Global Heparin Sodium Active Pharmaceutical Ingredient Production Capacity (2016-2026) & (Billion Units)
Figure 13. Global Heparin Sodium Active Pharmaceutical Ingredient Production Capacity by Geographic Region: 2020 VS 2021
Figure 14. Heparin Sodium Active Pharmaceutical Ingredient Market Drivers
Figure 15. Heparin Sodium Active Pharmaceutical Ingredient Market Restraints
Figure 16. Heparin Sodium Active Pharmaceutical Ingredient Market Trends
Figure 17. Global Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Manufacturer in 2020
Figure 18. Global Heparin Sodium Active Pharmaceutical Ingredient Revenue Market Share by Manufacturer in 2020
Figure 19. Heparin Sodium Active Pharmaceutical Ingredient Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. Top 3 Heparin Sodium Active Pharmaceutical Ingredient Manufacturer (Revenue) Market Share in 2020
Figure 21. Top 6 Heparin Sodium Active Pharmaceutical Ingredient Manufacturer (Revenue) Market Share in 2020
Figure 22. Global Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Region (2016-2026)
Figure 23. Global Heparin Sodium Active Pharmaceutical Ingredient Revenue Market Share by Region (2016-2026)
Figure 24. North America Heparin Sodium Active Pharmaceutical Ingredient Revenue (2016-2026) & (USD Million)
Figure 25. Europe Heparin Sodium Active Pharmaceutical Ingredient Revenue (2016-2026) & (USD Million)
Figure 26. Asia-Pacific Heparin Sodium Active Pharmaceutical Ingredient Revenue (2016-2026) & (USD Million)
Figure 27. South America Heparin Sodium Active Pharmaceutical Ingredient Revenue (2016-2026) & (USD Million)
Figure 28. Middle East & Africa Heparin Sodium Active Pharmaceutical Ingredient Revenue (2016-2026) & (USD Million)
Figure 29. Global Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Type (2016-2026)
Figure 30. Global Heparin Sodium Active Pharmaceutical Ingredient Revenue Market Share by Type (2016-2026)
Figure 31. Global Heparin Sodium Active Pharmaceutical Ingredient Price by Type (2016-2026) & (US$/Billion Untis)
Figure 32. Global Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Application (2016-2026)
Figure 33. Global Heparin Sodium Active Pharmaceutical Ingredient Revenue Market Share by Application (2016-2026)
Figure 34. Global Heparin Sodium Active Pharmaceutical Ingredient Price by Application (2016-2026) & (US$/Billion Untis)
Figure 35. North America Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Type (2016-2026)
Figure 36. North America Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Application (2016-2026)
Figure 37. North America Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Country (2016-2026)
Figure 38. North America Heparin Sodium Active Pharmaceutical Ingredient Revenue Market Share by Country (2016-2026)
Figure 39. United States Heparin Sodium Active Pharmaceutical Ingredient Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Canada Heparin Sodium Active Pharmaceutical Ingredient Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Mexico Heparin Sodium Active Pharmaceutical Ingredient Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Europe Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Type (2016-2026)
Figure 43. Europe Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Application (2016-2026)
Figure 44. Europe Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Country (2016-2026)
Figure 45. Europe Heparin Sodium Active Pharmaceutical Ingredient Revenue Market Share by Country (2016-2026)
Figure 46. Germany Heparin Sodium Active Pharmaceutical Ingredient Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. France Heparin Sodium Active Pharmaceutical Ingredient Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. United Kingdom Heparin Sodium Active Pharmaceutical Ingredient Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Russia Heparin Sodium Active Pharmaceutical Ingredient Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Italy Heparin Sodium Active Pharmaceutical Ingredient Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Region (2016-2026)
Figure 52. Asia-Pacific Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Application (2016-2026)
Figure 53. Asia-Pacific Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Region (2016-2026)
Figure 54. Asia-Pacific Heparin Sodium Active Pharmaceutical Ingredient Revenue Market Share by Region (2016-2026)
Figure 55. China Heparin Sodium Active Pharmaceutical Ingredient Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Japan Heparin Sodium Active Pharmaceutical Ingredient Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Korea Heparin Sodium Active Pharmaceutical Ingredient Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. India Heparin Sodium Active Pharmaceutical Ingredient Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Southeast Asia Heparin Sodium Active Pharmaceutical Ingredient Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Australia Heparin Sodium Active Pharmaceutical Ingredient Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South America Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Type (2016-2026)
Figure 62. South America Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Application (2016-2026)
Figure 63. South America Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Country (2016-2026)
Figure 64. South America Heparin Sodium Active Pharmaceutical Ingredient Revenue Market Share by Country (2016-2026)
Figure 65. Brazil Heparin Sodium Active Pharmaceutical Ingredient Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Argentina Heparin Sodium Active Pharmaceutical Ingredient Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Middle East & Africa Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Type (2016-2026)
Figure 68. Middle East & Africa Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Heparin Sodium Active Pharmaceutical Ingredient Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Heparin Sodium Active Pharmaceutical Ingredient Revenue Market Share by Country (2016-2026)
Figure 71. Turkey Heparin Sodium Active Pharmaceutical Ingredient Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Egypt Heparin Sodium Active Pharmaceutical Ingredient Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Heparin Sodium Active Pharmaceutical Ingredient Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. South Africa Heparin Sodium Active Pharmaceutical Ingredient Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source

---